BioLife Solutions Inc (BLFS) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $36.88 (+0.08%), Market cap $1.09B, 52-week low–high $18.15 ~ $28.79.
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible trans
Financial statements, price targets, institutional (13F) holdings and related news for BioLife Solutions Inc are updated in real time on BlackAll Trade.
BioLife Solutions Inc trades at $36.88 (+0.08%). Real-time quotes and charts are available on BlackAll Trade.
BioLife Solutions Inc has a market cap of about $1.09B.
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and